Seastar Medical Holding Corporation held its annual meeting of stockholders virtually on July 3, 2025. Stockholders approved the election of Eric Schlorff and Kenneth Van Heel as Class III Directors. An amendment and restatement of the company's 2022 Omnibus Equity Incentive Plan to increase the number of authorized shares of common stock and remove the evergreen provision was approved. The potential future sale and issuance of shares of common stock to Lincoln Park, in accordance with the Lincoln Park Purchase Agreement, was approved. The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, a proposal to adjourn or postpone the meeting if necessary was also approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.